Borrego, MR, Lopez-Bravo, DP, Vila, MM, Pérez-García, JM, Fernández, M, Tormo, SB, García-Saenz, JA, Lema, L, Garau, I, Cortez, P, Torres, AA, Conejo, EA, Calvo, I, Ferrer, N, Blancas, I, Amillano, K, Santasusagna, S, Benderra, MA, Alcalá-Lopez, D, Antonarelli, G, Sampayo-Cordero, M, Llombart-Cussac, A, Cortés, J. Liposomal irinotecan in patients with HER2-negative breast cancer and brain metastases: The PHENOMENAL phase 2 study. EUROPEAN JOURNAL OF CANCER. 2026; 233DOI:10.1016/j.ejca.2025.116161. PMID:41371050. IF:7.100(Q1/2D).

Toledano-Fonseca, M, Cano-Osuna, MT, Elez, E, Soto-Alsar, J, Paáez, D, Fernández-Montes, A, Graña, B, Salud, A, Yubero, A, Macías, I, Quintero, G, López-López, C, Fernández-Rodríguez, T, García-Ortiz, MV, Sastre, J, García-Alfonso, P, Rodríguez-Ariza, A, Aranda, E. Circulating hsa-miR-29c-3p and VEGF-A levels predict the response to FOLFIRI plus aflibercept in elderly metastatic colorectal cancer patients. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70103. PMID:40747746. IF:3.600(Q1/2D).

Bernardi, E, López-Lombardía, O, Olmedo-Saura, G, Pagonabarraga, J, Kulisevsky, J, Pérez-Pérez, J. Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers-A Scoping Review. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2026; 27(2)DOI:10.3390/ijms27020881. PMID:41596528. IF:4.900(Q1/3D).

Torres, G, Gracia-Lavedan, E, González, J, Henríquez-Beltrán, M, Targa, ADS, Royo, M, Bermúdez-López, M, Castro-Boqué, E, Valdivielso, JM, Pamplona, R, Mauricio, D, Lecube, A, Barbé, F, De Batlle, J, Miquel, E, Ortega, M, Portero-Otín, M, Jové, M, Hernández, M, Rius, F, Franch-Nadal, J, Castelblanco, E, Godoy, P, Martinez-Alonso, M, Simó, R, Hernández, C, Fernández, E. Skin advanced glycation end-products do not predict pulmonary function trajectories in adults from the ILERVAS cohort. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-025-33414-8. PMID:41535697. IF:3.900(Q1/2D).